We have previously explored the potential mechanism of genetically engineered bacteria Salmonella YB1 in the treatment of glioma and found that Salmonella YB1 inhibits the expression of glutathione peroxidase-4 and induces ferroptosis to suppress glioma growth (59). The gene discussed is GPX4; the disease is central nervous system cancer.